Skip to content
Search

Latest Stories

DHSC publishes second list of March price concessions

Kiran Paul
By Kiran PaulMar 20, 2020
Kiran Paul
See Full Bio

The Department of Health and Social Care on Thursday announced the second list of drug price concessions for March.

The list of prices, revealed by PSNC, is below. The negotiator said it is working on further concessionary prices on other drugs reported to be unavailable at the stated March 2020 Drug Tariff price.

The first list announced on 13 March can be seen here.

DrugPack sizePrice concession
Amiloride 5mg tablets28£27.50
Clonidine 25microgram tablets112£14.44
Co-careldopa 25mg/100mg tablets100£12.88
Cyanocobalamin 50microgram tablets50£9.84
Desmopressin 200microgram tablets30£22.70
Esomeprazole 20mg gastro-resistant capsules28£2.42
Fluoxetine 10mg capsules30£46.70
Fluoxetine 60mg capsules30£6.99
Lamotrigine 25mg dispersible tablets sugar free56£7.74
Meloxicam 7.5mg tablets30£3.15
Meloxicam 15mg tablets30£5.80
Perindopril erbumine 4mg tablets30£4.30
Pizotifen 1.5mg tablets28£5.35
Ranitidine 150mg tablets60£7.32
Ranitidine 300mg tablets30£6.80
Tacrolimus 0.1% ointment30g£18.20
Tolterodine 1mg tablets56£22.80
Tolterodine 2mg tablets56£23.99
Venlafaxine 75mg tablets56£14.22

Related News

New professional liability insurance policy for RPS members launched
News

RPS launches professional liability insurance for members

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling
News

Pharma imports to US surged in March as drugmakers look to avoid tariffs

WW International logo with bold bankruptcy notice and confident recovery statement

US diet company WeightWatchers files for bankruptcy

Scottish community pharmacist working in high street pharmacy with supportive environment
News

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Pharmacist declining participation in assisted dying under new UK legislation

It could take another four years for assisted dying to become law

Pic credit: iStock

Pharmacists to have choice to opt-out of assisted dying process

Pharmacists will not be forced to be a part in assisted dying cases with the MP leading the campaign expected to made amendments to the bill which is currently going through parliamentary process.

Kim Leadbeater, the MP behind the Terminally Ill Adults (End of Life) Bill, will say that “no person is under any duty to participate in the provision of assistance”.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc